Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Hepatocellular carcinoma (HCC) is receiving increased attention. This study was designed to investigate the effect of selective Cyclooxygenase-2 (COX-2) inhibitor, nimesulide, on the expression of Smad4 in human hepatocellular carcinoma HepG2.
Pubmed ID: 23112421
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Cell line Hep-G2 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentions